Evidence map›Paper›PMID 40650094›Full record

ArticleInternational journal of molecular sciences2025

The Utility of Sperm DNA Fragmentation as a Diagnostic Tool for Male Infertility and Its Predictive Value for Assisted Reproductive Technology Outcomes.

Coral Zurera-Egea, Sílvia Mateo, Sergi Novo, Marta Asensio, Montserrat Boada, Marta Antich, Sergi Rovira, Zaida Sarrate, Joan Blanco, Ester Anton

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Coral Zurera-EgeaGenetics of Male Fertility Group, Unitat de Biologia Cel lular, Departament de Biologia Cel lular, de Fisiologia i d'Immunologia, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallés, Spain.
Sílvia MateoDexeus Fertility, Department of Obstetrics, Gynecology and Reproductive Medicine, Hospital Universitari Dexeus, 08028 Barcelona, Spain.
Sergi NovoFertilab, 08017 Barcelona, Spain.
Marta AsensioReproclinic, 08011 Barcelona, Spain.
Montserrat BoadaDexeus Fertility, Department of Obstetrics, Gynecology and Reproductive Medicine, Hospital Universitari Dexeus, 08028 Barcelona, Spain.ORCID 0000-0003-0389-0638
Marta AntichFertilab, 08017 Barcelona, Spain.
Sergi RoviraFertilab, 08017 Barcelona, Spain.
Zaida SarrateGenetics of Male Fertility Group, Unitat de Biologia Cel lular, Departament de Biologia Cel lular, de Fisiologia i d'Immunologia, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallés, Spain.ORCID 0000-0001-9677-1376
Joan BlancoGenetics of Male Fertility Group, Unitat de Biologia Cel lular, Departament de Biologia Cel lular, de Fisiologia i d'Immunologia, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallés, Spain.ORCID 0000-0003-0647-3856
Ester AntonGenetics of Male Fertility Group, Unitat de Biologia Cel lular, Departament de Biologia Cel lular, de Fisiologia i d'Immunologia, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallés, Spain.ORCID 0000-0002-8914-2667

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya 2021SGR00122by Instituto de Salud Carlos III, Ministry of Science and Innovation, Government of Spain PI21/00564Universitat Autònoma de Barcelona UAB/PIF2022
6 · The paper itself

Abstract

Standard semen parameters remain the cornerstone of male infertility evaluation, though they often poorly reflect the likelihood of success in assisted reproductive technology (ART). This study evaluates sperm DNA fragmentation (SDF) as a diagnostic tool for male infertility and predictive biomarker for ART success. Semen samples were collected from 20 fertile donors and 40 infertile patients with abnormal semen parameters. A fraction of each sample was used for SDF assessment via TUNEL assay and flow cytometry, while the remaining portion was processed for conventional semen analysis and ART. Infertile patients exhibited higher SDF levels (32.77 ± 13.61%) compared to donors (22.19 ± 8.37%;

Indexed as

DNA FragmentationInfertility, MaleReproductive Techniques, AssistedSpermatozoaAdultFemaleHumansMaleROC CurveSemen AnalysisSperm Motilityblastocyst formationembryo qualityfertilizationimplantationinfertilitySDFseminal alterations

Identifiers

PMID40650094
PMCPMC12250217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.